HIV breakthrough drug stops transmission of virus
According to the scientists at the Scripps Research Institute in Florida, the drug blocks every kind of HIV-1 (the most prevalent in the human population and HIV-2 (mainly seen in west Africa) as well as SIV (simian immunodeficiency virus — the virus in primates).
“It also protects against much higher doses of virus than occur in most human transmission and does so for at least eight months after injection,” the institute said in a press statement.


